MLchartDataset catalogue

Defitelio

Term · Oncology and biomedicine · MLC-T-ONC-002339

A drug used to treat hepatic veno-occlusive disease (a condition in which small veins in the liver are blocked) in adults and children who also have kidney or lung problems after receiving a stem cell transplant. Defitelio may affect the cells that line the inside of blood vessels and may help improve blood flow inside the liver. Also called defibrotide sodium.

Table 1. Record
IdentifierMLC-T-ONC-002339
FieldOncology and biomedicine
Synonymsdefibrotide sodium
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-002339",
  "term": "Defitelio",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat hepatic veno-occlusive disease (a condition in which small veins in the liver are blocked) in adults and children who also have kidney or lung problems after receiving a stem cell transplant. Defitelio may affect the cells that line the inside of blood vessels and may help improve blood flow inside the liver. Also called defibrotide sodium.",
  "synonyms": [
    "defibrotide sodium"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/defitelio/"
}

Record 5,776 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.